Lower Graft-versus-Host Disease and Relapse Risk in Post-Transplant Cyclophosphamide–Based Haploidentical versus Matched Sibling Donor Reduced-Intensity Conditioning Transplant for Hodgkin Lymphoma

Document Details

Document Type
Pub Defense Publication
Publication Date
Sep 01, 2019
Source ID
10.1016/j.bbmt.2019.05.025

Entities

People

  • Abraham S. Kanate
  • Alberto Mussetti
  • Alex F. Herrera
  • Ana Sureda
  • Baldeep Wirk
  • Bipin N Savani
  • Carlos Litovich
  • David J. Inwards
  • Ephraim J. Fuchs
  • Hemant Murthy
  • Hisham Abdel-azim
  • Javier Bolaños-meade
  • Jean A. Yared
  • Jennifer A. Kanakry
  • Jonathon B. Cohen
  • Kwang Woo Ahn
  • Mahmoud Aljurf
  • Mehdi Hamadani
  • Miguel-Angel Perales
  • Nasheed Hossain
  • Nelli Bejanyan
  • Nilanjan Ghosh
  • Pashna N Munshi
  • Rizwan Romee
  • Rodrigo Martino
  • Sachiko Seo
  • Sairah Ahmed
  • Timothy S. Fenske
  • Umar Farooq
  • Vera Ulrike Bacher
  • Yago Nieto

Organizations

  • National Heart, Lung, and Blood Institute

Tags

Technology Areas

  • Biotechnology
  • Biotechnology - Cancer Biotech